During the past decade, Quest Research Institute - Hunt - PPDS conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quest Research Institute - Hunt - PPDS" #1 collaborator was "PPD" with 4 trials as a collaborator and "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Quest Research Institute - Hunt - PPDS" are "Cervical Dystonia" (2 trials), "Migraine" (2 trials), "Healthy Participants" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Quest Research Institute - Hunt - PPDS" in a lesser frequency.

Most popular intervention types in "Quest Research Institute - Hunt - PPDS" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "ABP-450" (4 trials), "Placebo" (3 trials) and "TAK-071" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quest Research Institute - Hunt - PPDS" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Quest Research Institute - Hunt - PPDS". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Quest Research Institute - Hunt - PPDS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quest Research Institute - Hunt - PPDS, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".